Since the addition of WT1 helper peptide on WT1-CTL peptide vaccination were reported to induce stronger WT1-specific CTL response and better clinical outcome,[13] these results suggested the possibility that increased FDG uptake of WT1-vaccinated skin assessed by PET-CT reflect the magnitude of anti-cancer immunity induced by WT1 vaccine therapy. Here, WT1 is linked to cancer.